H.R. 5853 · 112th Congress

Gray Market Drug Reform and Transparency Act of 2012

Stage
In committee
Introduced
2012-05-22
Latest action
2012-05-25 · Referred to the Subcommittee on Health.

Votes

No linked votes are available for this bill.